Skip to main content

Chlorogenic Acid

Last reviewed

Chlorogenic acid (CGA) is the polyphenol in green coffee separate from caffeine. It increases Type I collagen synthesis through the TGF-beta/Smad pathway while suppressing MMP-1 and MMP-3, a rare combination that supports ECM protection in hEDS and gentle pro-collagen activity simultaneously. ZebraThrive uses 200 mg CGA in the daily powder.

At a Glance

Daily Dose

200 mg CGA (Daily Powder)

Key Benefits

Increases Type I collagen synthesis via TGF-beta/Smad pathway at oral-achievable concentrations
Reduces MMP-1 and MMP-3 (matrix-degrading enzymes elevated in hEDS dermal fibroblasts)
Mast cell stabilization via PPAR-gamma and Akt1/NF-kB pathways
Decaffeinated green coffee bean sourcing avoids caffeine triggers common in MCAS and POTS

How It Works

Chlorogenic acid (CGA) is the polyphenol that gives green coffee beans most of their biological activity - separate from caffeine. For the triad, it brings three useful mechanisms: pro-collagen support in dermal fibroblasts at concentrations achievable from oral dosing, mast cell stabilization through both PPAR-gamma and NF-kB pathways, and modest cardiovascular support. Lab studies in skin fibroblasts show CGA increases Type I collagen synthesis through the TGF-β/Smad pathway while reducing MMP-1 and MMP-3 - a rare combination that supports ECM protection and gentle pro-collagen activity at the same time. We source from decaffeinated green coffee bean extract.

What the Research Shows

Chlorogenic acid increases Type I collagen synthesis in human dermal fibroblasts through TGF-beta/Smad signaling while simultaneously reducing MMP-1 and MMP-3 expression. The dual effect (pro-collagen plus MMP suppression) is a rare combination among polyphenols and avoids the anti-fibrotic risk that would be harmful in hEDS.

[1]Xue N et al., "Chlorogenic Acid Prevents UVA-Induced Skin Photoaging through Regulating Collagen Metabolism and Apoptosis in Human Dermal Fibroblasts"
PMID: 35805942
Mechanism: In Vitro

In vitro, human dermal fibroblasts under UVA-induced photoaging stress

CGA upregulated Col1 mRNA and protein expression in HDFs without affecting cell viability; under UVA stress, CGA decreased MMP-1 and MMP-3 levels while enhancing TGF-beta/Smad2/3 signaling for Col1 synthesis

Chlorogenic acids from green coffee extract are highly bioavailable in humans, with substantial conversion to active metabolites (caffeic, ferulic, dihydrocaffeic, dihydroferulic acids and their sulfate/glucuronide conjugates) detected in plasma and urine. Dose-dependent absorption with reduced relative bioavailability at the highest doses.

[2]Farah A et al., "Chlorogenic acids from green coffee extract are highly bioavailable in humans"
PMID: 19022950
Human Observational

Human PK study, n=10 healthy adults, decaffeinated green coffee extract 170 mg CGA

Approximately 33% of ingested cinnamic acid moieties recovered in plasma including metabolites; peak plasma levels 0.5-8 hours after dosing

[3]Stalmach A et al., "Impact of dose on the bioavailability of coffee chlorogenic acids in humans"
PMID: 24947504
Human RCT

Randomized double-blind crossover, n=11 healthy volunteers

Peak plasma concentrations 1.0-1.5 µmol/L total metabolites after 412-795 µmol CGA dose; 16-25% of dose recovered in urine over 24 hours

Meta-analytic and acute RCT evidence shows modest blood pressure effects, primarily in hypertensive populations, with neutral effects in normotensives. Acute endothelial function (flow-mediated dilation) improves at higher CGA doses.

[4]Ward NC et al., "Acute effects of chlorogenic acids on endothelial function and blood pressure in healthy men and women"
PMID: 27109860
Human RCT

Randomized crossover RCT, n=16 healthy adults

900 mg of 5-CGA significantly improved continuous mean post-ischemic flow-mediated dilation at 1 hour and 4 hours; no significant acute BP effect in normotensives

[5]Samavat S et al., "The effects of green coffee bean extract on blood pressure and heart rate: A systematic review and dose-response meta-analysis of randomized controlled trials"
PMID: 39368321
Human Meta/Review

Meta-analysis of 10 RCTs, n=563

Green coffee bean extract reduced systolic BP by 2.95 mmHg and diastolic BP by 2.15 mmHg overall; subgroup analysis showed greater effect in hypertensive populations and no effect in females; HR effect neutral

Addressing the Triad

Tailored benefits for complex conditions

MCAS

Chlorogenic acid stabilizes mast cells through two distinct pathways: it activates PPAR-gamma (the same receptor PEA targets) and inhibits the Akt1/NF-kB axis. A 2025 in vivo study showed CGA reduced histamine by 34% in a mast cell activation model. The mechanism is distinct from the calcium-influx-blocking pathway that luteolin and quercetin use, so CGA adds complementary coverage to the formulation. We chose the decaffeinated green coffee bean source specifically because caffeine itself is a documented MCAS trigger for many patients - getting the polyphenol without the caffeine is the entire point of this sourcing.

hEDS

CGA is one of the more interesting ECM-protective ingredients for hEDS because the dual mechanism (pro-collagen synthesis plus MMP-1/MMP-3 inhibition) happens at concentrations achievable from oral dosing, and without driving the anti-fibrotic activity that would be harmful for hEDS. That balance - supporting synthesis while protecting against degradation - is exactly the pattern an ECM-protective ingredient should hit for this population.

POTS

CGA's POTS relevance is the polyphenol family of effects: gentle support for endothelial function, modest BP effects (meaningful only in hypertensives, essentially neutral in normotensives), and trace cardiovascular benefits from reducing oxidative stress. The larger story for the triad is the mast cell side, since many POTS patients have overlapping MCAS, and CGA addresses both layers without the caffeine triggers that derail this population.

Why We Chose This Form

Decaffeinated green coffee bean extract, >=45% CGAs by HPLC (COA-verified)

We source chlorogenic acid from decaffeinated green coffee bean extract, standardized to ≥45% CGAs by HPLC. The decaf spec matters: residual caffeine at supplement doses can trigger mast cell activation in sensitive MCAS patients, and the autonomic symptoms of POTS often worsen with caffeine. Our spec calls for under 2% residual caffeine on the COA, preferring under 0.1% - well below the threshold that affects symptoms. We specify water/CO₂ extraction (non-fermented) to avoid the histamine and tyramine that can ride along with poorly-sourced botanical extracts. The dose is 200 mg per day, split AM and PM in the Daily Powder.

Safety & Interactions

Potential Side Effects

Excellent tolerability in human cardiovascular and metabolic trials at 200-400 mg/day. Mild GI discomfort possible at high single doses. The decaffeinated, non-fermented sourcing eliminates the caffeine and biogenic-amine triggers that affect this population.

Drug Interactions

Modest BP-lowering effect in hypertensive populations (2-3 mmHg systolic in meta-analyses); neutral in normotensives. If you are on midodrine or other BP-supporting medications and prone to symptomatic hypotension, mention CGA to your prescriber. CGA undergoes methylation clearance; the demand is small at 200 mg/day but we balance with methylfolate and methylated B12 in the formulation.

Excipients to Avoid

  • Fermented botanical sources
  • Residual caffeine above 2%
  • Artificial colors

Safe Excipients

  • HPMC capsules
  • Rice flour
  • Cellulose

  1. [1]Chlorogenic Acid Prevents UVA-Induced Skin Photoaging through Regulating Collagen Metabolism and Apoptosis in Human Dermal FibroblastsPMID: 35805942

    Xue N et al. (2022)

  2. [2]Chlorogenic acids from green coffee extract are highly bioavailable in humansPMID: 19022950

    Farah A et al. (2008)

  3. [3]Impact of dose on the bioavailability of coffee chlorogenic acids in humansPMID: 24947504

    Stalmach A et al. (2014)

  4. [4]Acute effects of chlorogenic acids on endothelial function and blood pressure in healthy men and womenPMID: 27109860

    Ward NC et al. (2016)

  5. [5]The effects of green coffee bean extract on blood pressure and heart rate: A systematic review and dose-response meta-analysis of randomized controlled trialsPMID: 39368321

    Samavat S et al. (2024)

Common Questions

It's the polyphenol found in coffee, but a useful supplement dose is far higher than coffee delivers, and coffee brings caffeine that's a problem for many in this community. Our CGA comes from decaffeinated green coffee bean extract (unroasted bean has higher CGA than roasted coffee) at under 2% residual caffeine. The active compound, none of the caffeine-driven mast cell or autonomic effects.

Probably not at our dose. The cleanest meta-analyses show CGA produces a modest 2-3 mmHg systolic drop in hypertensive populations, with the effect essentially disappearing in normotensives (the floor effect). For most POTS patients with normal or low BP, CGA shouldn't be a hypotensive concern. Earlier '−7 to −10 mmHg' claims came from a now-retracted study; the current evidence is much more modest. If you're already running low on midodrine, mention it to your prescriber.

Both, which is unusual for a single ingredient. The collagen and mast cell mechanisms run through separate signaling pathways (TGF-β/Smad for collagen, PPAR-gamma and NF-kB for mast cells), and the pro-collagen effect happens without driving the anti-fibrotic activity that would be harmful in hEDS. See the How It Works and Addressing the Triad sections above for the full mechanism walk.

CGA is partly cleared through methylation, so it does draw on the methyl donor pool - but the demand is small at 200 mg/day relative to total methylation throughput. We balance the formulation with methylfolate and methylated B12 to keep that pool topped up. If you have known MTHFR variants and significant methylation concerns, mention CGA to your prescriber, but most people tolerate it without issue. Common foods like coffee, tea, and apples contribute similar methylation load daily.

Written by Ken Chapman, Founder of ZebraThrive. Reviewed and last updated .

Z
ZebraThrive

Clinical-grade stability for the hyper-mobile and histamine-sensitive. Research-driven. Zero compromise.

Important: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Information on this site is for educational purposes only and is not a substitute for professional medical advice. Always consult your physician before starting any new supplement, especially if you take prescription medications or have a diagnosed medical condition.

© 2026 ZebraThrive. All rights reserved.Last updated